CD4+ effector T cells accelerate Alzheimer’s disease in mice
Jatin Machhi, Pravin Yeapuri, Yaman Lu et al. · Journal of Neuroinflammation · 2021
Full textCC BY
Physiology
Filters2 filters applied
Status
- Expression of concern
- Corrected
- No notice
- From publisher notices and Retraction Watch. Not checked means nobody has looked yet.
Year
Readable here
Study type
Licence
“Don’t Phos Over Tau”: recent developments in clinical biomarkers and therapies targeting tau phosphorylation in Alzheimer’s disease and other tauopathies
Yuxing Xia, Stefan Prokop, Benoit I. Giasson · Molecular Neurodegeneration · 2021 · Review
Full textCC BY
Diverse human astrocyte and microglial transcriptional responses to Alzheimer’s pathology
Amy M. Smith, Karen Davey, Stergios Tsartsalis et al. · Acta Neuropathologica · 2021
Full textCC BY
Protective genes and pathways in Alzheimer’s disease: moving towards precision interventions
Mabel Seto, Rebecca L. Weiner, Logan Dumitrescu et al. · Molecular Neurodegeneration · 2021 · Review
Full textCC BY
Soluble P‐tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau
Niklas Mattsson‐Carlgren, Shorena Janelidze, Randall J Bateman et al. · EMBO Molecular Medicine · 2021
Full textCC BY
Macrophage as a Peripheral Pain Regulator
Risa Domoto, Fumiko Sekiguchi, Maho Tsubota et al. · Cells · 2021 · Review
Full textCC BY
Aducanumab for Alzheimer’s disease?
Sebastian Walsh, Richard Merrick, Richard Milne et al. · BMJ · 2021
Full textCC BY
Endo-lysosomal Aβ concentration and pH trigger formation of Aβ oligomers that potently induce Tau missorting
Marie P. Schützmann, Filip Hasecke, Sarah Bachmann et al. · Nature Communications · 2021
Full textCC BY
TDP-43 Pathology in Alzheimer’s Disease
Axel Meneses, Shunsuke Koga, Justin O’Leary et al. · Molecular Neurodegeneration · 2021 · Review
Full textCC BY
Lipid Profiling of Alzheimer’s Disease Brain Highlights Enrichment in Glycerol(phospho)lipid, and Sphingolipid Metabolism
Sumeyya Akyol, Zafer Ugur, Ali Yilmaz et al. · Cells · 2021
Full textCC BY
The mechanistic link between selective vulnerability of the locus coeruleus and neurodegeneration in Alzheimer’s disease
Billie J. Matchett, Lea T. Grinberg, Panos Theofilas et al. · Acta Neuropathologica · 2021 · Review
Full textCC BY
β3-Adrenergic receptors regulate human brown/beige adipocyte lipolysis and thermogenesis
Cheryl Cero, Hannah J. Lea, Kenneth Y. Zhu et al. · JCI Insight · 2021
Full textCC BY
Insulin Resistance and Diabetes Mellitus in Alzheimer’s Disease
Jesús Burillo, Patricia Marqués, Beatriz Jiménez et al. · Cells · 2021 · Review
Full textCC BY
Novel Therapeutic Approaches for Alzheimer’s Disease: An Updated Review
Tien-Wei Yu, Hsien-Yuan Lane, Chieh-Hsin Lin · International Journal of Molecular Sciences · 2021 · Review
Full textCC BY
Senescence in Post-Mitotic Cells: A Driver of Aging?
Thomas von Zglinicki, Tengfei Wan, Satomi Miwa · Antioxidants & Redox Signaling · 2021 · Review
Full textCC BY
Sarcopenia and Menopause: The Role of Estradiol
Annalisa Geraci, Riccardo Calvani, Evelyn Ferri et al. · Frontiers in Endocrinology · 2021 · Review
Full textCC BY
Abnormal brain cholesterol homeostasis in Alzheimer’s disease—a targeted metabolomic and transcriptomic study
Vijay R. Varma, H. Büşra Lüleci, Anup M. Oommen et al. · npj Aging and Mechanisms of Disease · 2021
Full textCC BY
Ketogenic Diets and Chronic Disease: Weighing the Benefits Against the Risks
Lee Crosby, Brenda Davis, Shivam Joshi et al. · Frontiers in Nutrition · 2021 · Review
Full textCC BY
Epigenetics of Alzheimer’s Disease
Matea Nikolac Perkovic, Alja Videtic Paska, Marcela Konjevod et al. · Biomolecules · 2021 · Review
Full textCC BY
Performance on sit-to-stand tests in relation to measures of functional fitness and sarcopenia diagnosis in community-dwelling older adults
Xianyang Sherman Yee, Yee Sien Ng, John Carson Allen et al. · European Review of Aging and Physical Activity · 2021
Full textCC BY